Clinical Trial Update: Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study [NA]

View source ↗

Summary

A completed pilot clinical trial evaluating berberine for tolerability and its effects on major metabolic biomarkers in individuals with metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Metabolic Syndrome | NA | Status: COMPLETED